Cargando…

Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study Group

The clinical and biological characteristics of children under 2 years (infants) with acute myeloid leukemia (AML) are different from those of older children. We aimed to describe the specific characteristics of this population and the potential factors that influence the prognosis. We analyzed data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blais, S., Boutroux, H., Pasquet, M., Leblanc, T., Fenneteau, O., Gandemer, V., Bertrand, Y., Ducassou, S., Michel, G., Nelken, B., Petit, A., Cuccuini, W., Gouache, E., Renaut, Marceau-A., Baruchel, A., Lapillonne, H., Leverger, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924544/ https://www.ncbi.nlm.nih.gov/pubmed/31976488 http://dx.doi.org/10.1097/HS9.0000000000000316

Ejemplares similares

Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized Trial
por: Petit, Arnaud, et al.
Publicado: (2018)

Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group
por: Marceau-Renaut, Alice, et al.
Publicado: (2018)

Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study
por: Gouache, Elodie, et al.
Publicado: (2018)

Germline pathogenic variants in transcription factors predisposing to pediatric acute myeloid leukemia: results from the French ELAM02 trial
por: Fenwarth, Laurène, et al.
Publicado: (2020)

Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group
por: Lew-Derivry, Lucille, et al.
Publicado: (2023)

Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study
por: Ceraulo, Antony, et al.
Publicado: (2022)

Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity
por: Calvo, Charlotte, et al.
Publicado: (2021)

Elam on Cerebria
Publicado: (1873)

2nd ELAM Conference
por: Bott, R, et al.
Publicado: (1972)

COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)
por: Baruchel, André, et al.
Publicado: (2020)

Germline RUNX1 variants in paediatric patients in a French specialised centre
por: Liu, Cécile, et al.
Publicado: (2022)

COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)
por: Rouger-Gaudichon, Jérémie, et al.
Publicado: (2021)

ARID5B, IKZF1 and Non-Genetic Factors in the Etiology of Childhood Acute Lymphoblastic Leukemia: The ESCALE Study
por: Rudant, Jérémie, et al.
Publicado: (2015)

Household Exposure to Pesticides and Risk of Childhood Hematopoietic Malignancies: The ESCALE Study (SFCE)
por: Rudant, Jérémie, et al.
Publicado: (2007)

SNP-array lesions in core binding factor acute myeloid leukemia
por: Duployez, Nicolas, et al.
Publicado: (2018)

STUDIES ON THE MATURATION OF MYELOBLASTS INTO MYELOCYTES AND ON AMITOTIC CELL DIVISION IN THE PERIPHERAL BLOOD IN SUBACUTE MYELOBLASTIC LEUCEMIA
por: Sabin, F. R., et al.
Publicado: (1924)

Biallelic CXCR2 loss-of-function mutations define a distinct congenital neutropenia entity
por: Marin-Esteban, Viviana, et al.
Publicado: (2021)

Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study
por: Tabone, Marie-Dominique, et al.
Publicado: (2021)

A Case of Acute Myeloblastic Leukæmia
por: Fleming, Robert A., et al.
Publicado: (1924)

Granulocyte function in myeloblastic leukaemia.
por: Wilkinson, P. M., et al.
Publicado: (1975)

Childhood acute lymphoblastic leukaemia and indicators of early immune stimulation: the Estelle study (SFCE)
por: Ajrouche, R, et al.
Publicado: (2015)

Day-care, early common infections and childhood acute leukaemia: a multicentre French case–control study
por: Perrillat, F, et al.
Publicado: (2002)

Adiponectin in relation to childhood myeloblastic leukaemia
por: Petridou, E, et al.
Publicado: (2006)

Cytomegalovirus keratitis in acute myeloblastic leukemia
por: Daryabari, Seyed-Hashem, et al.
Publicado: (2023)

Assessment of Drug Sensitivity of Human Leukaemic Myeloblasts: I. Labelling Human Myeloblasts with (125)IUdR for Survival Studies in Mice
por: FalcãO, R. P., et al.
Publicado: (1977)

The effects of platelet activating factor and retinoic acid on the expression of ELAM-1 and ICAM-1 and the functions of neutrophils
por: Chen, Si-Feng
Publicado: (1995)

Actual biological diagnosis of acute myeloblastic leukemia in children
por: Buga Corbu, V, et al.
Publicado: (2014)

Late effects in survivors of infantile acute leukemia: a study of the L.E.A program
por: Gandemer, V, et al.
Publicado: (2017)

Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
por: Taylor, G. M., et al.
Publicado: (1976)

Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg(®)) in children with relapsed/refractory myeloid leukemia
por: Brethon, Benoit, et al.
Publicado: (2006)

Proceedings: Surface immunological markers in acute myeloblastic leukaemia.
por: Taylor, G. M., et al.
Publicado: (1975)

Expression of the p53 oncogene in acute myeloblastic leukemia
Publicado: (1986)

Medullary allotransplant in acute myeloblastic leukemia in a child
por: Buga Corbu, V, et al.
Publicado: (2014)

Label-free detection of leukemic myeloblasts in hyaluronic acid
por: Park, Suhyun, et al.
Publicado: (2022)

The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia.
por: Holmes, J. A., et al.
Publicado: (1994)

Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in mice.
por: Sonis, S. T., et al.
Publicado: (1977)

PB1781: THERAPEUTIC POTENTIAL OF DNA DAMAGE RESPONSE IN ACUTE MYELOBLASTIC LEUKEMIA
por: Lapa, B., et al.
Publicado: (2022)

T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia
Publicado: (1986)

Acute acalculous cholecystitis complicating chemotherapy for acute myeloblastic leukemia
por: Kassar, Olfa, et al.
Publicado: (2015)

Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors’ cohort: a comparison with controls from the French population
por: Oudin, Claire, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o1ft45qsjpqvk9h7npcdrnc05f